g
36 This result may be related to an improvement in insulin resistance as noted by differences in the HOMA-IR index or an effect on oxidant stress as described in other studies with carvedilol with metoprolol decreased insulin sensitivity and increased oxidative stress and the antifibrinolytic plasminogen activator inhibitor 1 in patients with metabolic syndrome, whereas nebivolol lacked detrimental metabolic effects
Studies have shown that nonselective propranolol, 18 β 1-selective atenolol, 19 and metoprolol 20 significantly decrease insulin sensitivity in patients with
Differential effects of nebivolol and metoprolol on insulin sensitivity and plasminogen activator inhibitor in the metabolic syndrome Early-generation β-blockers lower blood
It is regularly used in the Christchurch
Carvedilol, metoprolol, and insulin resistance A 9